IL38643A - 5-phenyl(or pyridyl)-1h-3-hydroxy-1,5-benzodiazepine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

5-phenyl(or pyridyl)-1h-3-hydroxy-1,5-benzodiazepine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL38643A
IL38643A IL38643A IL3864372A IL38643A IL 38643 A IL38643 A IL 38643A IL 38643 A IL38643 A IL 38643A IL 3864372 A IL3864372 A IL 3864372A IL 38643 A IL38643 A IL 38643A
Authority
IL
Israel
Prior art keywords
formula
effected
compound
compounds
reaction
Prior art date
Application number
IL38643A
Other languages
Hebrew (he)
Other versions
IL38643A0 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL38643A0 publication Critical patent/IL38643A0/en
Publication of IL38643A publication Critical patent/IL38643A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/121,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1374529 Benzodiazepines BOEHRINGER INGELHEIM GmbH 26 Jan 1972 [27 Jan 1971] 3719/72 Heading C2C Compounds of the general formula (R<SP>1</SP>=H, alkyl, alkenyl, hydroxyalkyl, cycloalkylalkyl; R 2 =unsubstituted or substituted Ph or Py; R 3 = halogen, CF 3 , NO 2 ) are prepared by (a) reducing a compound of the formula (b) mild oxidation of a compound of the formula (R 4 , R 5 =H, alkyl), or (c) reacting a compound of the formula (R 1 not H) with water, optionally followed in the case of (a) and (b) by introduction of a 1- substituent. The above compounds are tranquilizers and anti-convulsants, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier. [GB1374529A]

Claims (1)

1. 38643/2 1. Compounds of the general formula: wherein represents a hydrogen atom; a straight or branched alkyl group with 1 to 4 carbon atoms optionally substituted in the CJ position by a hydroxy group; or an allyl; represents a phenyl group which may if desired be substituted by a halogen atom or by a trifluoromethyl or nitro group; or a pyridyl group; and represents a fluorine, chlorine or bromine atom or a trifluoromethyl or nitro group. 38643/2 2. 1 Compounds as claimed in claim j 1 wherein represents a hydrogen atom or a me hyl or ethyl group; 1*2 represents a phenyl group which may if desired be substituted in the o-position by a tri- fluoromethyl group; or a pyridyl group and represents a chlorine or bromine atom or a trifluoromethyl group. 3, ; 3-Hydroxy-l-methyl-5-phenyl-7-chloro-lH-l , 5- benzodiazepine-2 ,4-(3H , 5H)rdione. 4. ' ' 3-Hydroxy-5-(o-trifluoromethylphenyl)-7-chloro- lH-1 ,5-benzodiazepine-2 ,4-(3H, 5H)-dione. 5. 7-Chloro-3-hydroxy-l-methyl-5-(o-trifluoromethyl- phenyl) -lH-1 , 5-benzodiazepine-2 ,4-(3H ,5H)-dione. 6. 7-Bromo-3-hydroxy-l-methyl-5-(a-pyridyl)-lH-l , 5- benzodiazepine-2 ,4-(3H , 5H)-dione. 7. Compounds as claimed in claim 1, other than as — ■' ' ¾ claimed in any of claims 3 to 6 , as herein specifically disclosed. 8. ' A process for the preparation of compounds as claimed in claim 1 which comprises reducing a compound of the formula 38643/2 (wherein R. , R. and R- are as defined in claim 1) or a 1 ' 2 3 I 1 hydrate thereof whereby a compound of formula I (as defined in claim 1) is obtained. I 9." A process as claimed in .claim 8 wherein the reduction is effected by the use of zinc/glacial acetic acid or tin/hydrochloric acid. 20. A process as claimed in claim 8 or claims 9 wherein the reduction is effected at an elevated temperature. .11· A process as claimed .in claim 8 wherein the reduction is effected catalytically or by the use of' an alkali metal borohydride. ^12.; A process as claimed in claim, 11 wherein the alkali metal borohyU > *i >Ie comprises sodium borohydride. 13. A process for the preparation of compounds as ···'■':..; claimed in claim 1 which comprises the mild oxidation of a compound of the formula: 38643/2 « "L (wherein R^, and are as defined in claim 1 and R^ and R,. which may be the same or different each : represent a hydrogen atom or a straight or branched alkyl group). ' 14. ! A process as claimed in claim 13 wherein a' compound of formula III is used in which ^ and/or j I R_ represents a straight or branched alkyl group with | 1 to 4 carbon atoms. 15· : A process as claimed in claim! 13 or claimj 14J wherein the mild oxidation is !effected by the use„of ! potassium permanganate or chromic acid. 16.1 A process as claimed in any of claimsj 13; to 14 i wherein the mild oxidation is effected at a low temperature. 17.j A process as claimed in any of claimsj 13- 1 toj 16 ' wherein the mild oxidation is effected in a weakly acidic medium. , iQe I' A process for the preparation of compounds as claimed in claim 1 (wherein R^ is other than hydrogen) 38643/3 which comprises reacting a compound of the formula: (wherein R^, and R^ are as defined in claim 1 with the proviso that R^ is other than hydrogen) to convert the compound of formula IV into a compound of formula ! I. I I 19, ί A process as claimed in claimj 18 ' wherein the reaction is effected by the use of water, 20» J A process as claimed in claim le or claim! 19 wherein the reaction is effected in the presence of an inert solvent, 21, Ί A process as claimed in any of claims, 18 to^' 20 wherein the reaction is effected in the presence of copper powder or a copper salt. 22. A process as claimed in claimj 21 wherein the copper salt is copper sulphate. 23.i A process for the preparation of compounds as claimed in claim 1 (wherein R^ is other than hydrogen) which comprises reacting a compound of the formula: 38643/5- H an appropriate alkylating or allylating agent whereby a compound of formula I as defined in claim 1 (wherein is other than hydrogen) is obtained. 24. A process as claimed in claim 23 wherein the alkylating, or allylating agent comprises an alkyl or allyl halide or a dialkyl or diallyl sulfate. 25. A modification of a process as claimed in claim 23 or claim 24 wherein an alkali metal salt of the compound of formula la (as defined in claim 23) is i . used in place of the compound of formula la (as defined in claim 23 ) . 26. A process for the preparation of compounds as claimed in claim l(wherein represents a hydroxy- alkyl group) which comprises reacting a compound of the formula 2 (wherein and are as defined in claim 1) with an alkylene oxide). ■ ; i , 27.1 A process as claimed in claim 26 wherein the I . reaction is effected in the presence of a strong base. Ί 1 _ ·_:_. : ' 28. A process as claimed in claimi26 or claimi27 Ί ; ' · '· ;■ wherein the reaction is effected in the presence of i i ■ : i an appropriate solvent or mixture of solvents. j 29. A process as claimed in any of claims 26 to 28 ,! wherein the solvent comprises an alcohol, tetrahydrofuran, i ■ ■· ,. or dimethylformamide. j j " 'Ί ,.. .. , .. . j ;30.j A process as claimed in any of claims|26 | o \ 291 | wherein the reaction is effected in the presence of water. 131 J A process for the preparation of compounds as claimed in cl alkyl group) of formula: 38643/3 (wherein anc* ^-3 are as def ned in claim 1) with haloalcohol with 1 to 4 carbon atoms. 32 j A process as claimed in claim, 31 wherein the reaction is effected in the presence of a weak inorganic or organic base. 33 . A process as claimed in claim 31 or claim 32 wherein the reaction is effected at an elevated temperature. 34. A process as claimed in any of claims 31 to 33 wherein the reaction is effected in the presence of an organic solvent. 35 . A process as claimed in claim 34 wherein the solvent comprises a lower or higher alcohol. 36 . A process as claimed in a'ny of claims 8 to 35 substantially as herein described. 37. A process for the preparation of compounds as claimed in claim 1, substantially as herein described in any of Examples 1 to ;26. 38. Compounds as claimed in claim 1 when prepared by a process as claimed in any of claims 8 to : 37. 39. Pharmaceutical compositions comprising as active ingredient at least one compound of formula I as claimed in any of claims 1 to 6 and 35 in association with a pharmaceutical carrier or excipient.
IL38643A 1971-01-27 1972-01-26 5-phenyl(or pyridyl)-1h-3-hydroxy-1,5-benzodiazepine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them IL38643A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712103745 DE2103745A1 (en) 1971-01-27 1971-01-27 New 5-AryJ- (or Heteroaryl) -3-hydroxylH-1,5-benzodiazepine-2,4- (3H, 5H) -diones and processes for their preparation

Publications (2)

Publication Number Publication Date
IL38643A0 IL38643A0 (en) 1972-03-28
IL38643A true IL38643A (en) 1976-01-30

Family

ID=5797047

Family Applications (1)

Application Number Title Priority Date Filing Date
IL38643A IL38643A (en) 1971-01-27 1972-01-26 5-phenyl(or pyridyl)-1h-3-hydroxy-1,5-benzodiazepine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
AT (3) AT315849B (en)
AU (1) AU464682B2 (en)
BE (1) BE778542A (en)
BG (3) BG19174A3 (en)
CA (1) CA967957A (en)
DD (1) DD99376A5 (en)
DE (1) DE2103745A1 (en)
DK (1) DK130411B (en)
ES (3) ES399169A1 (en)
FR (1) FR2123474B1 (en)
GB (1) GB1374529A (en)
HU (1) HU164575B (en)
IE (1) IE36035B1 (en)
IL (1) IL38643A (en)
NL (1) NL7201048A (en)
PL (3) PL91875B1 (en)
RO (3) RO60492A (en)
SU (3) SU493971A3 (en)
ZA (1) ZA72538B (en)

Also Published As

Publication number Publication date
BG21031A3 (en) 1976-01-20
DE2103745A1 (en) 1972-08-10
CA967957A (en) 1975-05-20
DK130411C (en) 1975-07-21
RO60491A (en) 1976-06-15
FR2123474A1 (en) 1972-09-08
IE36035L (en) 1972-07-27
PL91875B1 (en) 1977-03-31
SU493971A3 (en) 1975-11-28
BE778542A (en) 1972-07-26
SU465791A3 (en) 1975-03-30
PL84620B1 (en) 1976-04-30
ES425107A1 (en) 1976-07-01
RO60492A (en) 1976-06-15
AT315864B (en) 1974-06-10
DK130411B (en) 1975-02-17
ES399169A1 (en) 1975-06-01
HU164575B (en) 1974-03-28
ES425108A1 (en) 1976-07-01
RO61669A (en) 1976-11-15
AU464682B2 (en) 1975-08-20
GB1374529A (en) 1974-11-20
BG19174A3 (en) 1975-04-30
SU460627A3 (en) 1975-02-15
AU3836272A (en) 1973-08-02
IE36035B1 (en) 1976-08-04
AT316566B (en) 1974-07-25
BG19176A3 (en) 1975-04-30
PL84243B1 (en) 1976-03-31
NL7201048A (en) 1972-07-31
DD99376A5 (en) 1973-08-05
FR2123474B1 (en) 1975-10-10
IL38643A0 (en) 1972-03-28
AT315849B (en) 1974-06-10
ZA72538B (en) 1973-09-26

Similar Documents

Publication Publication Date Title
US3461461A (en) 6-amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidines
TERASHIMA et al. Studies on antiulcer agents. IV. Antiulcer effects of 2-benzylthio-5, 6, 7, 8-tetrahydro-4 (3H)-quinazolinones and related compounds
US3780040A (en) 2-substituted-3,4-dihydroquinazolines
US4159329A (en) 4-Pyrimidones compositions, and methods of use
EP0220786B1 (en) Substituted quinazolinones
US3949089A (en) Substituted guanidine compounds as antifibrillatory agents
GB1601195A (en) 4-acylamino-or 4-acylaminoalkyl-benzoic acids derivatives thereof and processes for their manufacture
NZ209548A (en) Antibacterial solutions of piperazinyl-quinolones and-azaquinolines
EP0154885B1 (en) Substituted 2-phenyl-hexahydro-1,2,4-triazine-2,5-diones, method for their preparation, their use as veterinary medicines and for combating protozoes
CA1225091A (en) Benzoquinolizine carboxylic acid derivatives, and process for preparation thereof
SK279326B6 (en) Antihypertensive compounds and pharmaceutical agent with antihypertensive effect
US4550101A (en) Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia
NZ206957A (en) 4-cyano-pyridazines; intemediates and pharmaceutical compositions
US4025607A (en) Propargyl-substituted 2-phenylamino-2-imidazolines and salts thereof
HU9401823D0 (en) Substituted imidazole derivatives, pharmaceutical compositions containing them and process for producing them
IL38643A (en) 5-phenyl(or pyridyl)-1h-3-hydroxy-1,5-benzodiazepine-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
ES8606283A1 (en) Quinolinecarboxylic acid derivatives.
US4058612A (en) 6-(Polyhaloisopropyl)quinazoline-2,4-diones
GB2069492A (en) Novel sulphur compounds
KR960703895A (en) Antibacterial quinolinyl- (1H-1,2,4-triazol-1-yl) alkanol derivatives
CA2216288C (en) Uracilic hydroquinone derivatives as type iv allergy inhibitors
US3621026A (en) Blood-sugar-lowering sulfonylamino pyrimidines
AU1971688A (en) Benzimidazole derivatives, their preparation and their application in therapeutics
US4143143A (en) Substituted imidazo[5,1-a]isoquinolines
US3840539A (en) Phthalazine derivatives